Alzheimer’s Expected to Cost U.S. $200B

The Alzheimer’s Association recently released its 2012 Alzheimer’s Disease Facts and Figures report, noting the direct costs of caring and treatment for Alzheimer’s patients will cost the United States roughly $200 billion this year, including $140 billion in costs to Medicare and Medicaid.

Advertisement

The average Medicare payment for a person with Alzheimer’s or other dementias is roughly three times higher than patients without those conditions. Medicaid payments are 19 times higher.

By 2050, the Alzheimer’s Association estimated the healthcare costs of Alzheimer’s, the sixth-leading cause of death in the United States, will be $1.1 trillion, which includes a 500 percent increase in combined Medicare and Medicaid spending.

More Articles on Hospital Neurology:

Study: Stroke Hospitalization Costs Driven by Neuroimaging

7 Ways to Enhance a Hospital Neurosurgery Department

HHS Releases Draft of National Plan to Fight Alzheimer’s Disease

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.